VTYX- Ventyx Biosciences, Inc.

Name: Ventyx Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ventyx Biosciences, Inc. (VTYX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. VTYX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Mohan Raju	2.37M	$18.32M	-
Other	Nuss John	489.5K	$3.78M	-
Other	Forman Mark S	6.0K	$6.2K	-
VP	Gonzales Roy	5.3K	$5.5K	-
Dir	White William Richard	0	-	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 30, 2023	Gujrathi Sheila	Director	Sale+OE	100,000	$33.73	$3,373,240.00	-100%	-4.1%	-83.7%
Jan 23, 2023	White William Richard	Director	Sale+OE	33,353	$35.10	$1,170,591.65	-48.6%	+12.3%	-94.2%
Dec 22, 2022	Mohan Raju83	Chief Executive Officer	Sell	55,354	$31.61	$1,749,640.30	-3.3%	+18.3%	-93.1%
Dec 22, 2022	Nuss John79	Chief Scientific Officer	Sell	13,812	$31.61	$436,653.95	-5.3%	+18.3%	-93.1%
Dec 22, 2022	Krueger Christopher W82	Chief Business Officer	Sell	3,654	$31.61	$115,517.92	-1.3%	+18.3%	-93.1%
Dec 16, 2022	Subramaniam Somu89	Director, 10% Owner	Sell	300,000	$33.28	$9,985,024.31	-1.1%	+11.3%	-93.1%
Dec 16, 2022	Nsv Partners III LP89	10% Owner	Sell	300,000	$33.28	$9,985,024.31	-1.1%	+11.3%	-93.1%
Dec 14, 2022	Sandborn William J.91	See Remarks	Sale+OE	42,682	$33.87	$1,445,717.51	-33.9%	+11.4%	-93.1%
Dec 13, 2022	Krueger Christopher W82	Chief Business Officer	Sell	30,000	$34.46	$1,033,668.00	-9.9%	+11.4%	-93.1%
Dec 13, 2022	Nuss John79	Chief Scientific Officer	Sell	35,000	$34.32	$1,201,077.50	-13.5%	+11.4%	-93.1%

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC